1350 related articles for article (PubMed ID: 25547266)
1. Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.
Tolmachov OE
Artif Intell Med; 2015 Jan; 63(1):1-6. PubMed ID: 25547266
[TBL] [Abstract][Full Text] [Related]
2. Split vector systems for ultra-targeted gene delivery: a contrivance to achieve ethical assurance of somatic gene therapy in vivo.
Tolmachov OE
Med Hypotheses; 2014 Aug; 83(2):211-6. PubMed ID: 24854575
[TBL] [Abstract][Full Text] [Related]
3. Tightly-wound miniknot vectors for gene therapy: a potential improvement over supercoiled minicircle DNA.
Tolmachov OE
Med Hypotheses; 2010 Apr; 74(4):702-4. PubMed ID: 19914006
[TBL] [Abstract][Full Text] [Related]
4. Subcellular post-transcriptional targeting: delivery of an intracellular protein to the extracellular leaflet of the plasma membrane using a glycosyl-phosphatidylinositol (GPI) membrane anchor in neurons and polarised epithelial cells.
Brown O; Cowen RL; Preston CM; Castro MG; Lowenstein PR
Gene Ther; 2000 Nov; 7(22):1947-53. PubMed ID: 11127583
[TBL] [Abstract][Full Text] [Related]
5. Stent-mediated gene delivery for site-specific transgene administration to the airway epithelium and management of tracheobronchial tumors.
Kruklitis RJ; Fishbein I; Singhal S; Kapoor V; Levy RJ; Alferiev IS; Sterman DH
Respiration; 2014; 88(5):406-17. PubMed ID: 25323160
[TBL] [Abstract][Full Text] [Related]
6. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells.
Fechner H; Wang X; Wang H; Jansen A; Pauschinger M; Scherübl H; Bergelson JM; Schultheiss HP; Poller W
Gene Ther; 2000 Nov; 7(22):1954-68. PubMed ID: 11127584
[TBL] [Abstract][Full Text] [Related]
7. Transgenic DNA modules with pre-programmed self-destruction: Universal molecular devices to escape 'genetic litter' in gene and cell therapy.
Tolmachov OE
Med Hypotheses; 2015 Nov; 85(5):686-9. PubMed ID: 26319641
[TBL] [Abstract][Full Text] [Related]
8. Virus-mimetic polyplex particles for systemic and inflammation-specific targeted delivery of large genetic contents.
Kang S; Lu K; Leelawattanachai J; Hu X; Park S; Park T; Min IM; Jin MM
Gene Ther; 2013 Nov; 20(11):1042-52. PubMed ID: 23759703
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
Ulrich-Vinther M
Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
[TBL] [Abstract][Full Text] [Related]
10. Self-entanglement of long linear DNA vectors using transient non-B-DNA attachment points: a new concept for improvement of non-viral therapeutic gene delivery.
Tolmachov OE
Med Hypotheses; 2012 May; 78(5):632-5. PubMed ID: 22356834
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
[TBL] [Abstract][Full Text] [Related]
12. Progress in transcriptionally targeted and regulatable vectors for genetic therapy.
Miller N; Whelan J
Hum Gene Ther; 1997 May; 8(7):803-15. PubMed ID: 9143906
[TBL] [Abstract][Full Text] [Related]
13. Durable and stratum-specific gene expression in epidermis.
Ghazizadeh S; Doumeng C; Taichman LB
Gene Ther; 2002 Oct; 9(19):1278-85. PubMed ID: 12224010
[TBL] [Abstract][Full Text] [Related]
14. Targeting of polyplexes: toward synthetic virus vector systems.
Wagner E; Culmsee C; Boeckle S
Adv Genet; 2005; 53():333-54. PubMed ID: 16241000
[TBL] [Abstract][Full Text] [Related]
15. Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications.
Chung IM; Ueno H; Pak YK; Kim JW; Choi DH; Shin GJ; Yang WI; Jang Ys
Exp Mol Med; 2002 Sep; 34(4):299-307. PubMed ID: 12515396
[TBL] [Abstract][Full Text] [Related]
16. Hybrid vector designs to control the delivery, fate and expression of transgenes.
Lam PY; Breakefield XO
J Gene Med; 2000; 2(6):395-408. PubMed ID: 11199260
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
[TBL] [Abstract][Full Text] [Related]
18. Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand.
Hoganson DK; Sosnowski BA; Pierce GF; Doukas J
Mol Ther; 2001 Jan; 3(1):105-12. PubMed ID: 11162317
[TBL] [Abstract][Full Text] [Related]
19. Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR.
Jiang L; Rampalli S; George D; Press C; Bremer EG; O'Gorman MR; Bohn MC
Gene Ther; 2004 Jul; 11(13):1057-67. PubMed ID: 15152187
[TBL] [Abstract][Full Text] [Related]
20. A novel strategy of cell targeting based on tissue-specific expression of the ecotropic retrovirus receptor gene.
Igarashi T; Suzuki S; Takahashi M; Tamaoki T; Shimada T
Hum Gene Ther; 1998 Dec; 9(18):2691-8. PubMed ID: 9874267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
